Chronic Obstructive Pulmonary Disease News and Research RSS Feed - Chronic Obstructive Pulmonary Disease News and Research

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
Smoke from indoor biomass fuel linked to COPD among rural women in Bangladesh

Smoke from indoor biomass fuel linked to COPD among rural women in Bangladesh

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in the world. [More]
Acute COPD exacerbations linked to long-term decline in lung function

Acute COPD exacerbations linked to long-term decline in lung function

Acute exacerbations of chronic obstructive pulmonary disease, or COPD, are associated with significant long-term lung function loss, according to research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. [More]
Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Researchers at Helmholtz Zentrum München, a partner in the German Center for Lung Research, have discovered that the number of myeloid-derived suppressor cells (MDSC) is increased in the blood of patients with idiopathic pulmonary fibrosis (IPF). [More]
Hospitals with high readmission rates more likely to show better mortality scores

Hospitals with high readmission rates more likely to show better mortality scores

A group of Johns Hopkins physicians and researchers today published an article in the Journal of Hospital Medicine suggesting that data on mortality and hospital readmission used by the United States Centers for Medicare and Medicaid suggest a potentially problematic relationship. [More]
Researchers discover olfactory receptors in human muscle cells of bronchi

Researchers discover olfactory receptors in human muscle cells of bronchi

Researchers identified two types of olfactory receptors in human muscle cells of bronchi. If those receptors are activated by binding an odorant, bronchi dilate and contract - a potential approach for asthma therapy. [More]
New drug could help decrease symptoms of asthma

New drug could help decrease symptoms of asthma

The first new asthma pill for nearly 20 years has the power to significantly reduce the severity of the condition, a study led by the University of Leicester has found. [More]
High medical costs force many Australians to skip healthcare treatment

High medical costs force many Australians to skip healthcare treatment

New research shows one in four chronically ill Australians is skipping healthcare because of high costs. [More]
Review highlights role of N-acetylcysteine in clinical management of COPD

Review highlights role of N-acetylcysteine in clinical management of COPD

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death of United States and is associated with a significant number of hospital admissions per year among patients. [More]
Northwell Health receives grant to assess pulmonary rehabilitation via telehealth for Hispanic COPD patients

Northwell Health receives grant to assess pulmonary rehabilitation via telehealth for Hispanic COPD patients

Northwell Health's Feinstein Institute for Medical Research has been awarded a $1.5 million grant from the Patient-Centered Outcomes Research Institute to study whether home-based pulmonary rehabilitation improves quality of life and decreases hospitalization in Hispanic patients with moderate to severe chronic obstructive pulmonary disease (COPD). [More]
GSK, VentureWise partner to deliver independent educational program on COPD to GPs

GSK, VentureWise partner to deliver independent educational program on COPD to GPs

A new agreement between GlaxoSmithKline and VentureWise—part of the MedicineWise Group—will see an independent educational program delivered to GPs on the topic of chronic obstructive pulmonary disease. [More]
Scientists develop prediction score to identify older adults at risk of developing pneumonia

Scientists develop prediction score to identify older adults at risk of developing pneumonia

In a study published in the Journal of American Geriatrics Society, researchers developed a "prediction score" to help healthcare professionals determine which older adults might be most at risk for developing pneumonia. [More]

Pulmatrix announces positive results from Phase 1 study of novel dry powder formulation in COPD patients

Pulmatrix, Inc., today announced positive topline data from a Phase 1 pilot pharmacokinetic bioavailability trial of PUR0200. PUR0200 is a novel dry powder formulation of a currently marketed once daily bronchodilator, formulated in the company's proprietary iSPERSETM dry powder delivery technology. [More]
New opioid use among older adults with COPD linked to increased risk for respiratory-related death

New opioid use among older adults with COPD linked to increased risk for respiratory-related death

Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital researchers have found. [More]
Deuteration offers alternative chorea treatment for Huntington disease patients

Deuteration offers alternative chorea treatment for Huntington disease patients

Treatment with a deuterated form of tetrabenazine has resulted in improved motor signs among patients with Huntington disease, making it a potential treatment for chorea, trial findings show. [More]
Simple 7-item screening device can help detect patients at risk for COPD

Simple 7-item screening device can help detect patients at risk for COPD

A simple 7-item screening tool can help clinicians identify patients at risk for chronic obstructive pulmonary disease (COPD), even if they are not experiencing any symptoms. [More]
Study highlights need to improve end-of-life care for all patients with serious illnesses

Study highlights need to improve end-of-life care for all patients with serious illnesses

Historically, efforts to improve end-of-life care have focused primarily on patients with cancer. But few studies have looked at the quality of end-of-life care for patients with other serious illnesses, such as lung, kidney or heart failure or dementia. [More]
Depression reduces COPD maintenance medication adherence in older adults

Depression reduces COPD maintenance medication adherence in older adults

A recent study in the Annals of the American Thoracic Society found that in a nationally representative sample of Medicare beneficiaries who were newly diagnosed with COPD, adherence to maintenance medications decreased with new episodes of depression. [More]
Researchers reveal novel mechanism of smoke induced collapse of protein homeostasis in COPD

Researchers reveal novel mechanism of smoke induced collapse of protein homeostasis in COPD

Few threats to public health are as perilous as cigarette smoking, with more than 435,000 Americans dying each year of tobacco-related pulmonary illnesses such as chronic obstructive pulmonary disease (COPD). [More]
E-cigarette use modifies gene expression important for upper airway immune defense

E-cigarette use modifies gene expression important for upper airway immune defense

When we smoke cigarettes, dozens of genes important for immune defense are altered in the epithelial cells that line the respiratory tract. Several of these changes likely increase the risk of bacterial infections, viruses, and inflammation. [More]
Rehabilitation programmes can help reverse frailty in older COPD patients

Rehabilitation programmes can help reverse frailty in older COPD patients

One in four patients with COPD referred for exercise rehabilitation are frail, but nevertheless can respond favourably to rehabilitation and their frailty can be reversed, finds a new study led by King's College London and Royal Brompton & Harefield NHS Foundation Trust. [More]
Advertisement
Advertisement